Macular Disease Foundation Australia logo

    MDFA News

    Saving sight will save billions of dollars

    An investment to save the sight of thousands of vulnerable older Australians will save the Government up two billion dollars.

    Read more
    Back

    Most recent

    My Eyes offers a new way to support AMD patients.

    My Eyes offers a new way to support AMD patients.

    Evaluation of MDFA’s education courses for health professionals

    Evaluation of MDFA’s education courses for health professionals

    Partnership to address Diabetic Eye Disease in Indigenous communities

    A successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.

    New stem cell models for dry AMD

    A years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.

    Vabysmo® (faricimab) now available in Australia 

    Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia

    Welcome Dr. Kathy Chapman

    MDFA welcomed Dr Kathy Chapman as CEO in July

    Digital Diagnosis and Artificial Intelligence: Seeking Your Views  

    Attend any medical congress and you’ll increasingly hear the terms “artificial intelligence” and “digital diagnosis”

    Ophthalmologists needed for IVI digital support program

    Ophthalmologists needed for IVI digital support program

    Loading...
    Loading...